The Market and Potential for Molecular Point of Care (mPOC), 2021

$4,000.00$8,000.00

Description:

Kalorama Information’s latest report, The Market and Potential for Molecular Point of Care (mPOC), 2021, provides comprehensive market sizing, forecasting, trend mapping, and competitive analysis for point of care (POC) tests using PCR or other molecular technologies. Designed for near-patient settings, these tests offer fast turnaround times. Major in vitro diagnostic (IVD) companies such as Abbott, Roche, and Quidel are key competitors, alongside numerous new entrants.

Report Highlights

  • Molecular Point of Care (mPOC) Systems: mPOC systems are faster than lab-based tests and more accurate than traditional POC systems. These devices, marketed outside the reference lab, run PCR or other DNA and RNA tests on small-footprint devices. Featuring cartridges or simplified preparation steps, mPOC systems deliver results quickly enough for office visits or bedside consultations.
  • Impact of COVID-19: Initially a niche market, mPOC has seen significant growth due to the COVID-19 pandemic. The ability to provide rapid PCR results has highlighted the value of mPOC systems, driving market adoption and expansion. This report offers a complete update on mPOC’s role in COVID-19 testing and other growth areas.
  • Market Data and Analysis: The report includes detailed information on current mPOC systems, market size and growth projections from 2020 to 2025, and competitor analysis. Key data points include:
    • Current Molecular POC Systems
    • Molecular Point of Care Market: 2020-2025
    • COVID-19 mPOC Market
    • Molecular Point of Care Market Share by Vendor, 2020 ($M, %)
    • Small-Footprint Molecular Point of Care Market, 2020 (%)
    • Geographic Breakout of the Molecular Point of Care Market, 2020 (N. America, Europe, APAC, RoW)
    • Segment Breakout of Molecular Point of Care Market, 2020 (Respiratory vs. Other)
    • Breakout of Molecular Point of Care Market, 2020 (%; Respiratory, Other)
    • Respiratory Segment Breakout, 2020 (Flu, RSV, Strep, Other)
    • Breakout of mPOC Respiratory, 2020 (%; Flu, Strep, RSV, Other)
    • Near Patient Molecular IVD Market: 2020-2025
    • Near Patient Molecular Market Share by Vendor, 2020

Trends and Insights

The report covers a wide range of trends influencing the mPOC market, including:

  • Menu expansion and new system development
  • Disease statistics and impact on market growth
  • The COVID-19 crisis and its effect on market dynamics
  • Competition from immunoassay and enhancement of competitive POC systems
  • Emerging markets and their contributions to market growth
  • Recent journal studies on mPOC efficacy

Company Profiles

In-depth profiles of major players in the mPOC market provide insights into company strategies, market positioning, and competitive dynamics.

For further details and to purchase directly, please contact us.

Sample Report: A sample is available as a PDF upon request.

LICENSE

, ,